Sign in

NCT05121545Active, not recruiting

Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors

A Phase 1 Study of Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors (ProGRID)

Source: ClinicalTrials.gov · Last updated 29 Jan 2026

Brief summary (registry, in English)

This is a single arm, phase I study, evaluating the feasibility, toxicity, and degree of tumor response after novel proton pencil beam scanning (PBS GRID) treatment in patients with bulky tumors that are difficult to manage.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
11 (actual)
First submitted
4 Nov 2021
Start date
6 Apr 2022
Primary completion date
24 Sept 2024
Lead sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Diseases
Melanoma, Sarcoma
NCT number
NCT05121545

What you commit to

  • Study type: Interventional
  • Participants enrolled: 11
  • From 6 Apr 2022 to the primary completion date, 24 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • For patients with prior RT that overlaps with Pro-GRID: Dicoms not available Pregnant women

Age

  • Age \< 18

Other

  • ECOG performance status 3-4
  • Planned for definitive, curative management
  • Tumor encasing critical structure, as defined by the treating MD.

Who the study is looking for

  • Age \> 18
  • Histologically or cytologically confirmed invasive cancer
  • Bulky tumor \> 7 cm, determined clinically and/or radiographically, at the time of evaluation prior to enrollment
  • Treated indicated for palliative intent
  • Eastern Cooperative Oncology Group (ECOG) performance status \< 2
  • Anticipated treatment deemed safe on pre-review by PI
  • For patients with prior Radiation Therapy (RT): Dicoms must be available for dose fusion if overlap anticipated with GRID
  • Willing and able to provide informed consent
  • Discussion with medical oncology or surgical specialty

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Sibley Memorial Hospital
Coordinator of this site? Confirm its status
Washington D.C.United StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.